microRNA-10b: a new marker or the marker of pancreatic ductal adenocarcinoma?
- PMID: 21816909
- DOI: 10.1158/1078-0432.CCR-11-1477
microRNA-10b: a new marker or the marker of pancreatic ductal adenocarcinoma?
Abstract
microRNA-10b (miR-10b) expression in pancreatic ductal adenocarcinoma (PDAC), as identified by in situ hybridization, is highly correlated with cancer diagnosis, therapy response, and prognosis. If these findings are further confirmed in prospective studies, miR-10b could be used to improve the management of PDAC and decrease the mortality rate of this deadly cancer.
©2011 AACR.
Comment on
-
MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma.Clin Cancer Res. 2011 Sep 1;17(17):5812-21. doi: 10.1158/1078-0432.CCR-11-0695. Epub 2011 Jun 7. Clin Cancer Res. 2011. PMID: 21652542 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
